XML 42 R26.htm IDEA: XBRL DOCUMENT v3.22.1

Note 2 - Revenue Recognition (Tables)

12 Months Ended

Mar. 31, 2022

Notes Tables

Disaggregation of Revenue [Table Text Block]

		Year Ended March 31, 2022
		Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Clinical Genomics (1)				Corporate and Other				Total
Discrete Revenues
Consumables		$	50,311			$	15,551			$	3,675			$	22,271			$	-			$	91,808
Hardware and Software			700				21,651				28,537				6,726				-				57,614
Services			2,225				3,864				11,212				1,796				-				19,097
Contracted Revenues
Services			5,808				4,513				3,448				2,047				-				15,816
Total Revenues		$	59,044			$	45,579			$	46,872			$	32,840			$	-			$	184,335

		Year Ended March 31, 2021
		Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Clinical Genomics (1)				Corporate and Other				Total
Discrete Revenues
Consumables		$	45,869			$	13,942			$	3,198			$	-			$	-			$	63,009
Hardware and Software			505				13,545				29,969				-				-				44,019
Services			1,848				2,928				10,850				-				-				15,626
Contracted Revenues
Services			4,897				3,477				2,909				-				-				11,283
Total Revenues		$	53,119			$	33,892			$	46,926			$	-			$	-			$	133,937

		Year Ended March 31, 2020
		Sterilization and Disinfection Control				Biopharmaceutical Development (2)				Calibration Solutions				Clinical Genomics (1)				Corporate and Other				Total
Discrete Revenues
Consumables		$	42,654			$	4,981			$	3,240			$	-			$	2,436			$	53,311
Hardware and Software			551				6,015				33,524				-				-				40,090
Services			1,592				1,761				11,556				-				27				14,936
Contracted Revenues
Services			4,863				1,094				3,393				-				-				9,350
Total Revenues		$	49,660			$	13,851			$	51,713			$	-			$	2,463			$	117,687

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities as of March 31, 2021		$	8,994
Prior year liabilities recognized in revenues during the year ended March 31, 2022			(5,791	)
Contract liabilities added during the year ended March 31, 2022, net of revenues recognized			11,866
Contract liabilities balance as of March 31, 2022		$	15,069

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration